Opus Genetics, Inc.
(IRD - NASDAQ)
5,12 USD
📋 Profilo Aziendale

Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders.

|